{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/dyspepsia-proven-gord/","result":{"data":{"firstChapter":{"id":"2b894900-36e2-56c8-9d00-aea95f9acd57","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 5f8864ca-7136-4e8e-8f95-35f009ace42d --><h1>Dyspepsia - proven GORD: Summary</h1><!-- end field 5f8864ca-7136-4e8e-8f95-35f009ace42d -->","htmlStringContent":"<!-- begin item 89b740bd-7667-4bf9-ae5f-d5c56f018af0 --><!-- begin field ea1822a6-fb18-4ebe-af19-4163adbc7485 --><ul><li>The term 'dyspepsia' is used to describe a complex of upper gastrointestinal tract symptoms which are typically present for four or more weeks, including upper abdominal pain or discomfort, heartburn, acid reflux, nausea and/or vomiting.</li><li>Gastro-oesophageal reflux disease<strong> </strong>(GORD) is usually a chronic condition where there is reflux of gastric contents back into the oesophagus, causing predominant symptoms of heartburn and acid regurgitation.</li><li>'Proven GORD'<strong> </strong>refers to endoscopically-determined reflux disease, which may be due to:<ul><li>Oesophagitis, when oesophageal inflammation and mucosal erosions are seen.</li><li>Endoscopy-negative reflux disease<strong> </strong>(or non-erosive reflux disease), when a person has symptoms of GORD but endoscopy is normal.</li></ul></li><li>Risk factors for developing GORD may include:<ul><li>Lifestyle factors, such as obesity, trigger foods, smoking, alcohol, coffee, and stress.</li><li>Drugs that decrease the lower oesophageal sphincter pressure, such as calcium-channel blockers, anticholinergics, theophylline, benzodiazepines, and nitrates.</li><li>Pregnancy.</li></ul></li><li>The annual risk of recurrence of untreated GORD symptoms is 50%, and the lifetime risk of recurrence is 80%. GORD symptoms are more likely to relapse in people with severe oesophagitis.<ul><li>10–15% of people with GORD will develop Barrett's oesophagus, and 1–10% of these will develop oesophageal adenocarcinoma over the next 10–20 years.</li></ul></li><li>Initial management of GORD symptoms should include:<ul><li>Advice on lifestyle measures and sleeping with the head of the bed raised.</li><li>Reviewing and stopping any drugs that may be exacerbating symptoms, if possible and appropriate.</li><li>Offering a full-dose PPI for 4 weeks for proven GORD, to aid healing.</li><li>Offering a full-dose PPI for 8 weeks for proven severe oesophagitis, to aid healing.</li></ul></li><li> If there are refractory or recurrent symptoms, management should include:<ul><li>Considering whether an alternative diagnosis such as cardiac or hepatobiliary disease is contributing to symptoms.</li><li>Checking the person's adherence to initial management.</li><li>Reinforcing lifestyle advice.</li><li>Prescribing a further 4 weeks of the initial PPI at full-dose or double-dose, or adding in a histamine (H<sub>2</sub>)-receptor antagonist (H<sub>2</sub>RA) at bedtime, for people with confirmed oesophagitis.</li><li>Switching to an H<sub>2</sub>RA for people with confirmed endoscopy-negative reflux disease.</li><li>Prescribing a high dose of the initial PPI for 8 weeks, or switching to an alternative full-dose or high-dose PPI for 8 weeks, if there is confirmed severe oesophagitis.</li><li>Offering a full-dose PPI long-term as maintenance treatment if symptoms of severe oesophagitis are controlled.</li></ul></li><li>People on long-term treatment for GORD symptoms should be:<ul><li>Offered an annual review.</li><li>Encouraged to step down or stop treatment, if possible and appropriate.</li></ul></li><li>Referral to a gastroenterologist or upper gastrointestinal surgeon should be considered for people with GORD symptoms that are:<ul><li>Refractory to treatment, persistent, or unexplained.</li><li>Controlled on acid suppression therapy, but the person does not want to continue treatment long-term or cannot tolerate treatment.</li><li>Associated with risk factors for Barrett's oesophagus.</li></ul></li></ul><!-- end field ea1822a6-fb18-4ebe-af19-4163adbc7485 --><!-- end item 89b740bd-7667-4bf9-ae5f-d5c56f018af0 -->","topic":{"id":"83831d3c-e98d-5e82-9fb9-cbd189e834d5","topicId":"8116d56b-de40-4191-af22-5152cc8f533c","topicName":"Dyspepsia - proven GORD","slug":"dyspepsia-proven-gord","aliases":[],"chapters":[{"id":"2b894900-36e2-56c8-9d00-aea95f9acd57","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"491fd89e-ec21-5541-b37c-3579bd40472f","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"6d91073e-8bb8-57e8-8ebf-c1b2832b3377","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"69955f21-cf75-5568-9c39-b6894659d140","slug":"changes","fullItemName":"Changes"},{"id":"69e41821-9e9f-506e-bf29-9bb662d19fc5","slug":"update","fullItemName":"Update"}]},{"id":"a5332092-2e76-52c3-9c78-c55c73be1c36","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"ac987149-bd5e-543a-8025-d0a50c72b165","slug":"goals","fullItemName":"Goals"},{"id":"c282f1cd-c0cd-5cc2-b030-047fa174fc2b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"35e91b3d-56f5-5130-8d0e-f0ad612196a3","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"fac73702-952e-57cf-a136-d52c4400cf78","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8add7bfe-1e06-5768-958d-3c09d529c285","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"bb66df20-4142-59d4-913e-cf945ca4dacc","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d0449fde-d38f-58a1-aee2-098d0ab6ff60","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"0a206efc-7aca-58e6-8462-5278f905b372","slug":"definition","fullItemName":"Definition"},{"id":"ce8c37c8-0936-52a2-87a7-0cbf130e1ce3","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"e1423a90-52a5-592c-ba4d-7f5a420ac54a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"cac2f410-0ab9-55d6-8bb8-acbe7735bd9c","slug":"complications","fullItemName":"Complications"},{"id":"9047f011-fcc3-521a-a802-30ac67c85c10","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"a4a2f3e7-53b3-50ce-b717-6a6e8e5a219d","slug":"management","fullItemName":"Management","subChapters":[{"id":"6898f6b1-0345-5601-a084-c0f92474d0c9","slug":"dyspepsia-proven-gord","fullItemName":"Scenario: Dyspepsia - proven GORD"}]},{"id":"adea4c6d-b925-5d85-92be-9d322d882faf","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"bda71033-db69-5e58-977e-9d415fe4f646","slug":"proton-pump-inhibitors","fullItemName":"Proton pump inhibitors"},{"id":"15ddfd64-70ae-5a0e-b1ca-6b8811278010","slug":"h2-receptor-antagonists","fullItemName":"H2-receptor antagonists"}]},{"id":"dc717df5-19a4-5e7d-8391-be3e281ebdc8","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"70508c23-67ec-5f56-b6cd-a9612c7e4e9f","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"713a3147-c4ed-5200-a0ab-51e195929400","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a10b2f69-154b-5dcc-8599-ae8de77e7eda","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"6155a413-aefc-5575-b07c-111ad7697022","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f73cf98a-26ab-5f78-b8e4-d24d5a849283","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"94379789-e6c4-55fa-b460-965e551f4ea7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"64699d48-46e4-5ff1-97c0-8e280c75065c","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"83831d3c-e98d-5e82-9fb9-cbd189e834d5","topicId":"8116d56b-de40-4191-af22-5152cc8f533c","topicName":"Dyspepsia - proven GORD","slug":"dyspepsia-proven-gord","aliases":[],"topicSummary":"The term 'dyspepsia' is used to describe a complex of upper gastrointestinal tract symptoms","lastRevised":"Last revised in April 2017","nextPlannedReviewBy":"2022-04-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2022-03","nextPlannedReviewByDisplay":"March 2022","specialities":[{"id":"e4fd15e3-ef70-523f-843c-5270742f518d","name":"Gastrointestinal","slug":"gastrointestinal"}],"chapters":[{"id":"2b894900-36e2-56c8-9d00-aea95f9acd57","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"491fd89e-ec21-5541-b37c-3579bd40472f","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"6d91073e-8bb8-57e8-8ebf-c1b2832b3377","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"69955f21-cf75-5568-9c39-b6894659d140","slug":"changes","fullItemName":"Changes"},{"id":"69e41821-9e9f-506e-bf29-9bb662d19fc5","slug":"update","fullItemName":"Update"}]},{"id":"a5332092-2e76-52c3-9c78-c55c73be1c36","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"ac987149-bd5e-543a-8025-d0a50c72b165","slug":"goals","fullItemName":"Goals"},{"id":"c282f1cd-c0cd-5cc2-b030-047fa174fc2b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"35e91b3d-56f5-5130-8d0e-f0ad612196a3","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"fac73702-952e-57cf-a136-d52c4400cf78","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8add7bfe-1e06-5768-958d-3c09d529c285","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"bb66df20-4142-59d4-913e-cf945ca4dacc","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d0449fde-d38f-58a1-aee2-098d0ab6ff60","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"0a206efc-7aca-58e6-8462-5278f905b372","slug":"definition","fullItemName":"Definition"},{"id":"ce8c37c8-0936-52a2-87a7-0cbf130e1ce3","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"e1423a90-52a5-592c-ba4d-7f5a420ac54a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"cac2f410-0ab9-55d6-8bb8-acbe7735bd9c","slug":"complications","fullItemName":"Complications"},{"id":"9047f011-fcc3-521a-a802-30ac67c85c10","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"a4a2f3e7-53b3-50ce-b717-6a6e8e5a219d","slug":"management","fullItemName":"Management","subChapters":[{"id":"6898f6b1-0345-5601-a084-c0f92474d0c9","slug":"dyspepsia-proven-gord","fullItemName":"Scenario: Dyspepsia - proven GORD"}]},{"id":"adea4c6d-b925-5d85-92be-9d322d882faf","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"bda71033-db69-5e58-977e-9d415fe4f646","slug":"proton-pump-inhibitors","fullItemName":"Proton pump inhibitors"},{"id":"15ddfd64-70ae-5a0e-b1ca-6b8811278010","slug":"h2-receptor-antagonists","fullItemName":"H2-receptor antagonists"}]},{"id":"dc717df5-19a4-5e7d-8391-be3e281ebdc8","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"70508c23-67ec-5f56-b6cd-a9612c7e4e9f","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"713a3147-c4ed-5200-a0ab-51e195929400","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a10b2f69-154b-5dcc-8599-ae8de77e7eda","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"6155a413-aefc-5575-b07c-111ad7697022","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f73cf98a-26ab-5f78-b8e4-d24d5a849283","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"94379789-e6c4-55fa-b460-965e551f4ea7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"64699d48-46e4-5ff1-97c0-8e280c75065c","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"83831d3c-e98d-5e82-9fb9-cbd189e834d5"}},"staticQueryHashes":["3666801979"]}